Uses of this Supplement
Chronic Fatigue Syndrome
Parkinson's Disease
Premenstrual Syndrome (PMS)
  Supplements with Similar Uses
View List by Use
  Drugs that Interact
Amphetamine-containing Medications
Ephedrine-containing Medications
Levodopa-containing Medications
Morphine Sulfate
Phenylpropanolamine - containing Medications
  Supplements with Similar Side Effects
View List by Side Effect
  Supplements with Similar Warnings
View List by Warning
  Learn More About
Look Up > Supplements > Tyrosine > Interactions
Interactions with Tyrosine
Amphetamine; Ephedrine; Phenylpropanolamine

L-tyrosine (200 and 400 mg/kg) significantly potentiated the anorexigenic effects of phenylpropanolamine (5, 10, or 20 mg/kg), ephedrine (5, 10, or 20 mg/kg), and amphetamine (0.75, 1.25, or 1.75 mg/kg) in a dose-dependent manner in rats (Hull and Maher 1990). More research is needed to determine whether L-tyrosine supplementation would produce similar results in humans.


Levodopa (L-dopa) may decrease tyrosine and tryptophan levels (Riederer 1980). However, administering L-dopa with tyrosine may decrease absorption of the amino acid by competitively inhibiting the transport system (Awad 1984).

Morphine Sulfate

L-tyrosine increased morphine-induced analgesia 154% in mice; only the L-form of tyrosine produced these effects (Hull et al. 1994). Further studies are needed to determine whether L-tyrosine would potentiate the analgesic activity of morphine in humans.


Awad AG. Diet and drug interactions in the treatment of mental illness – a review. Can J Psychiatry. 1984;29:609-613.

Hull KM, Maher TJ. L-Tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats. J Pharmacol Exp Ther. 1990;255(2):403-409.

Hull KM, Tolland DE, Maher TJ. L-tyrosine potentiation of opioid-induced analgesia utilizing the hot-plate test. J Pharmacol Exp Ther. 1994;269(3):1190-1195.

Riederer P. L-Dopa competes with tyrosine and tryptophan for human brain uptake. Nutr Metab. 1980;24(6):417-423.

Copyright © 2000 Integrative Medicine Communications

This publication contains information relating to general principles of medical care that should not in any event be construed as specific instructions for individual patients. The publisher does not accept any responsibility for the accuracy of the information or the consequences arising from the application, use, or misuse of any of the information contained herein, including any injury and/or damage to any person or property as a matter of product liability, negligence, or otherwise. No warranty, expressed or implied, is made in regard to the contents of this material. No claims or endorsements are made for any drugs or compounds currently marketed or in investigative use. The reader is advised to check product information (including package inserts) for changes and new information regarding dosage, precautions, warnings, interactions, and contraindications before administering any drug, herb, or supplement discussed herein.